» Articles » PMID: 39738847

Causal Association Between Bone Mineral Density and the Risk of Joint Replacement in Patients with Osteoarthritis: a Mendelian Randomization Study

Overview
Journal Clin Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2024 Dec 31
PMID 39738847
Authors
Affiliations
Soon will be listed here.
Abstract

Population-based studies have been inconsistent in terms of the relationship between bone mineral density (BMD) and the progression of osteoarthritis. This study aimed to evaluate the causal relationship between BMD and the risk of joint replacement in patients with osteoarthritis. We performed a two-sample Mendelian randomization (MR) analysis to determine the association of BMD of the total body, femoral neck, and lumbar spine with the risk of hip and knee replacements. Inverse variance weighting (IVW) was used as the main analysis method. Heterogeneity and horizontal pleiotropy were checked. Multivariable MR analysis was performed by adjusting for hip/knee pain, body mass index (BMI), estrogen levels, BMI-based sex hormone-binding globulin (SHBG) levels, and physical activity. BMD of the total body and the lumbar spine were significantly associated with higher risks of both knee (IVW odds ratios (ORs) = 1.08-1.10, p = 4.62E-03) and hip replacements (IVW ORs = 1.19-1.37, P = 3.23E-09). Femoral neck BMD was significantly associated with the risk of hip but not knee replacement (IVW OR = 1.27, 95% confidence interval 1.13 to 1.43, p = 9.15E-05). Multivariable MR analyses produced similar results compared to the univariable analyses. No evidence of heterogeneity and horizontal pleiotropy were found, except that there was heterogeneity in the association between total body BMD and the risk of knee replacement. BMD is significantly associated with an increased risk of both knee and hip replacement, and the association is stronger for hip replacement. These findings suggest a causal relationship between BMD and the progression of osteoarthritis. Key Points • BMD is associated with an increased risk of hip and knee joint replacement. • BMD was more strongly associated with hip replacement risk.

Citing Articles

Unraveling the brain-joint axis: genetic, transcriptomic, and cohort insights from neuroticism to osteoarthritis.

Zhang J, Li Y, Li Y, Liu H Mamm Genome. 2025; .

PMID: 40080206 DOI: 10.1007/s00335-025-10112-4.

References
1.
Felson D, Neogi T . Osteoarthritis: is it a disease of cartilage or of bone?. Arthritis Rheum. 2004; 50(2):341-4. DOI: 10.1002/art.20051. View

2.
Burr D, Gallant M . Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012; 8(11):665-73. DOI: 10.1038/nrrheum.2012.130. View

3.
Neogi T, Felson D . Osteoarthritis: Bone as an imaging biomarker and treatment target in OA. Nat Rev Rheumatol. 2016; 12(9):503-4. PMC: 4995125. DOI: 10.1038/nrrheum.2016.113. View

4.
Castaneda S, Roman-Blas J, Largo R, Herrero-Beaumont G . Subchondral bone as a key target for osteoarthritis treatment. Biochem Pharmacol. 2011; 83(3):315-23. DOI: 10.1016/j.bcp.2011.09.018. View

5.
Hart D, Mootoosamy I, Doyle D, Spector T . The relationship between osteoarthritis and osteoporosis in the general population: the Chingford Study. Ann Rheum Dis. 1994; 53(3):158-62. PMC: 1005278. DOI: 10.1136/ard.53.3.158. View